The mostcommon semaglutide side effects are gastrointestinal, not gynecological
Kpke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I
Keep the semaglutide in its original packaging
The SURPASS-CVOT trial, which directly compared these two medications in over 13,000 people with type 2 diabetes, found that tirzepatide produced approximately 12% weight loss compared with 5% for dulaglutide over 4 years
Patient case studies and success stories Many patient case studies and success stories show how semaglutide can make a big difference
And heres the encouraging part: all those metabolic improvements you made on GLP-1sthe weight loss, better insulin sensitivity, improved hormone balancethose benefits often stick around and make managing your condition easier even on different medications